ストックスクリーナーアプリを入手
22.69
3.68%
0.805
前日終値:
$21.89
開ける：
$21.91
24時間の取引高:
59,981
Relative Volume:
1.09
時価総額：
$207.93M
収益：
$103.14M
当期純損益:
$-5.82M
株価収益率:
-5.213
EPS:
-4.3526
ネットキャッシュフロー:
$2.14M
1週間 パフォーマンス:
-0.13%
1か月 パフォーマンス:
+7.74%
6か月 パフォーマンス:
-9.96%
1年 パフォーマンス:
-20.86%
1日の値動き範囲:
$21.87
$22.89
1週間の範囲:
$20.47
$23.66
52週間の値動き範囲:
$16.05
$35.95
Sanara Medtech Inc Stock (SMTI) Company Profile
Compare SMTI vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
22.69 | 200.55M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-15 | 開始されました | Lake Street | Buy |
| 2025-03-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-12-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-20 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc (SMTI) 最新ニュース
Sanara MedTech Inc. (SMTI) Tops Q3 Earnings Estimates - MSN
Sanara MedTech Shareholders Reaffirm Board and Governance Policies - TipRanks
Sanara MedTech (SMTI) investors approve board, auditor and 3-year say-on-pay cycle - Stock Titan
Responsive Playbooks and the SMTI Inflection - Stock Traders Daily
[Form 4] Sanara MedTech Inc. Insider Trading Activity - Stock Titan
Sanara MedTech (SMTI) director receives 4,154 restricted shares, total holdings 26,858 - Stock Titan
Sanara MedTech (SMTI) director Ronald Nixon receives 4,154 restricted shares grant - Stock Titan
Sanara MedTech director granted 4,385 restricted shares | SMTI Insider Trading - Stock Titan
Sanara MedTech Ends Catalyst Advisory Deal, Refocuses Strategy - TipRanks
Sanara Medtech Terminates Services Agreement With Catalyst Effective June 2 - TradingView
Sanara MedTech Ends Advisory Services Agreement With The Catalyst Group Amid Strategy Shift - TradingView
Sanara MedTech (NASDAQ: SMTI) terminates Catalyst advisory agreement - Stock Titan
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - AOL.com
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript - The Motley Fool
SMTI Stock Price, Quote & Chart | SANARA MEDTECH INC (NASDAQ:SMTI) - ChartMill
Sanara MedTech Inc. (SMTI) Slides as Support Test Looms; Medtech Sector Sentiment WeighsIchimoku Entry - The Legal Advocate
Sanara MedTech (SMTI) Falls 4.2% as Selling Pressure Intensifies Near SupportFloat Adjusted Cap - newsline.com
Sanara MedTech (SMTI) Gains 1.75% as Stock Tests Key Resistance LevelGEX Level - newsline.com
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript - AOL.com
Understanding the Setup: (SMTI) and Scalable Risk - Stock Traders Daily
Sanara MedTech Dips After Swing to Profit - Bez Kabli
Sanara MedTech (SMTI) Edges Lower Amid Modest Trading, Holds Above Key SupportMarket Leader Picks - The Legal Advocate
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
How The Sanara MedTech (SMTI) Narrative Is Shifting As The US$34 Target Stays Put - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTech Inc. (SMTI) And Encourages Shareholders to Connect - ACCESS Newswire
Sanara MedTech (SMTI) Q1 2026 Earnings: EPS $0.05 Beats EstimatesReturn On Equity - The Legal Advocate
Sanara MedTech (SMTI) Q1 2026 Earnings Beat: Revenue $N/A, EPS $0.05Viral Trade Signals - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - PR Newswire
Pomerantz LLP investigates Sanara MedTech for p... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Sanara MedTech (SMTI) CEO reports share withholding to cover tax on vested stock - Stock Titan
Sanara MedTech Inc. (SMTI) Investigation: Bronstein, Gewirtz & Gr - The National Law Review
The Technical Signals Behind (SMTI) That Institutions Follow - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
2026-05-15 | Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc. (SMTI) Stockholders to Inquire about Securities Investigation | NDAQ:SMTI | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Sanara MedTech: From Cash Burner To Profitable Growth (NASDAQ:SMTI) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Investors to Reach Out - ACCESS Newswire
Sanara MedTech Inc. (NASDAQ:SMTI) Q1 2026 Earnings Call Transcript - Insider Monkey
Sanara MedTech Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Sanara outlines Q2 2026 net revenue of $28.5M-$29.5M while reaffirming $116M-$121M full-year outlook - MSN
Lake Street Maintains Sanara MedTech(SMTI.US) With Buy Rating, Maintains Target Price $32 - 富途牛牛
Sanara MedTech (SMTI) posts Q1 2026 profit as revenue reaches $27.8M - Stock Titan
Sanara MedTech Inc (SMTI) Q1 2026 Earnings Call Highlights: Stro - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Sanara MedTech (SMTI) Reports Strong Q1 Revenue Growth and Impro - GuruFocus
2026-05-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sanara MedTech Inc. (SMTI) And Encourages Stockholders to Reach Out | NDAQ:SMTI | Press Release - Stockhouse
Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges - Investing.com
Earnings call transcript: Sanara MedTech Q1 2026 beats EPS expectations, stock surges By Investing.com - Investing.com South Africa
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call - Benzinga
Sanara MedTech Sees 2Q Rev $28.5M-$29.5M >SMTI - Moomoo
Sanara Medtech Inc (SMTI) 財務データ
収益
当期純利益
現金流量
EPS
1.68%
0.71%
大文字化:
|
ボリューム (24 時間):